Esperion Therapeutics
Lisa Schafer has a diverse and extensive work experience spanning several roles and industries. Lisa is currently the VP and Head of Marketing at Esperion since October 2022. Prior to this, they held various leadership positions at Sanofi from 2018 to 2022, including VP and Head of US Ped Vaccines Business Unit, VP and Head of Mainline Portfolio Vaccines, AVP and Head of Pediatric and Boosters Franchise, New Product Development Lead for RSV, and AVP and Head of US PRALUENT. Before joining Sanofi, Lisa worked at Merck, where they held roles such as Global Marketing Leader for Antibiotic New Products, ZERBAXA, and imipenem/relebactam, Global Marketing Leader for BELSOMRA, Consumer and Patient Lead for BELSOMRA Marketing team, HCP and Consumer Promotion Lead, Market Research Analyst, Sales Representative, and Information Technology Analyst.
Lisa Schafer has a BBA in Information Systems from Loyola University Maryland. Additionally, they hold an MBA in Finance and Marketing from Seton Hall University.
This person is not in any offices
Esperion Therapeutics
2 followers
Through scientific and clinical excellence, and a deep understanding of cholesterol biology, the experienced Lipid Management Team at ESPERION is committed to developing new LDL-C lowering medicines that will make a substantial impact on reducing global cardiovascular disease, the leading cause of death around the world.